Safety Evaluation of Antituberculosis Drugs During Pregnancy: A Systematic Review and Meta-Analysis
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Safety Evaluation of Antituberculosis Drugs During Pregnancy: A Systematic Review and Meta-Analysis
Authors
Keywords
-
Journal
Frontiers in Surgery
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2022-04-06
DOI
10.3389/fsurg.2022.871321
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pharmacokinetics and Safety of 3 Months of Weekly Rifapentine and Isoniazid for Tuberculosis Prevention in Pregnant Women
- (2021) Jyoti S Mathad et al. CLINICAL INFECTIOUS DISEASES
- Treatment and pregnancy outcomes of pregnant women exposed to second-line anti-tuberculosis drugs in South Africa
- (2021) Idah Mokhele et al. BMC Pregnancy and Childbirth
- Maternal and infant outcomes among pregnant women treated for multidrug/rifampicin-resistant tuberculosis in South Africa
- (2020) Marian Loveday et al. CLINICAL INFECTIOUS DISEASES
- The safety of isoniazid tuberculosis preventive treatment in pregnant and postpartum women: systematic review and meta-analysis
- (2020) Yohhei Hamada et al. EUROPEAN RESPIRATORY JOURNAL
- Individual and Composite Adverse Pregnancy Outcomes in a Randomized Trial on Isoniazid Preventative Therapy Among Women Living With HIV
- (2020) Gerhard Theron et al. CLINICAL INFECTIOUS DISEASES
- The predicted impact of tuberculosis preventive therapy: the importance of disease progression assumptions
- (2020) Tom Sumner et al. BMC INFECTIOUS DISEASES
- World Health Organization recommendations on the treatment of drug-resistant tuberculosis, 2020 update
- (2020) Fuad Mirzayev et al. EUROPEAN RESPIRATORY JOURNAL
- Tuberculosis Control: WHO Perspective and Guidelines
- (2019) Avinash Kanchar et al. INDIAN JOURNAL OF PEDIATRICS
- Isoniazid Preventive Therapy and Pregnancy Outcomes In HIV-Infected Women in the Tshepiso Cohort
- (2019) Nicole Salazar-Austin et al. CLINICAL INFECTIOUS DISEASES
- Isoniazid Preventive Therapy in HIV-Infected Pregnant and Postpartum Women
- (2019) Amita Gupta et al. NEW ENGLAND JOURNAL OF MEDICINE
- Population Pharmacokinetics of Isoniazid, Pyrazinamide, and Ethambutol in Pregnant South African Women with Tuberculosis and HIV
- (2019) Mahmoud Tareq Abdelwahab et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Safety and Effectiveness of Isoniazid Preventive Therapy in Pregnant Women Living with Human Immunodeficiency Virus on Antiretroviral Therapy: An Observational Study Using Linked Population Data
- (2019) Emma Kalk et al. CLINICAL INFECTIOUS DISEASES
- Exposure to first line anti-tuberculosis drugs in prepubertal age reduces the quality and functional competence of spermatozoa and oocytes in Swiss albino mice
- (2019) Arpitha Rao et al. ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY
- Social representations of mother-to-child transmission of HIV and its prevention in narratives by young Africans from five countries, 1997–2014: Implications for communication
- (2018) Kate Winskell et al. SOCIAL SCIENCE & MEDICINE
- Tuberculosis Case Finding in HIV-Infected Pregnant Women in Kenya Reveals Poor Performance of Symptom Screening and Rapid Diagnostic Tests
- (2016) Sylvia M. LaCourse et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Treatment for Tuberculosis Infection With 3 Months of Isoniazid and Rifapentine in New York City Health Department Clinics
- (2015) Natalie L. Stennis et al. CLINICAL INFECTIOUS DISEASES
- Preventing Tuberculosis Among HIV-Infected Pregnant Women in Lesotho
- (2014) Appolinaire Tiam et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- High Prevalence of Pulmonary Tuberculosis but Low Sensitivity of Symptom Screening among HIV-Infected Pregnant Women in South Africa
- (2013) Christopher J. Hoffmann et al. PLoS One
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started